Clinical trial reportThe Lancet. Child & adolescent healthPublished
Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, GSK, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- The Lancet. Child & adolescent health
- Published
- Topic
- Clinical care
- Subject terms
- Humans; HIV-1; HIV Infections; Pyridones; Anti-HIV Agents; Drug Therapy, Combination; Viral Load; Adolescent; Child; South Africa; United States; Female
- PubMed ID
- 42838065
- Added to directory
- Source checked